Given the prominent interplays among the three druggable tumorigenic factors—namely RORγ, PBK, and AR—further investigations are warranted to define the role of phosphorylation and ubiquitination in control of RORγ functions in prostate cancer and to elucidate the mechanisms underlying the interactions among the three proteins. The gene discussed is AR; the disease is Familial prostate cancer.